NTAP vs RGNX · P/E 28, rev $6.24B vs rev $114.4M
NetApp Inc (NTAP) versus Regenxbio Inc (RGNX) — a side-by-side from cached financials, not a winner call.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Regenxbio Inc (RGNX) is a biotechnology company listed on US.
Latest reported NTAP revenue for 2026-04-24 was $6.24B. Net income was $1.28B. Revenue was down 5.1% from 2025-04-25 to 2026-04-24. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Latest reported RGNX revenue for 2026-06-30 was $114.4M. Net income was -$67.3M. RGNX currently screens at market cap $440.4M.
NTAP currently screens at market cap $35.43B and trailing P/E 28.2. RGNX currently screens at market cap $440.4M.
Not investment advice. Open the NTAP and RGNX stock pages for the full models.
Not investment advice.